Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07470008 · ClinicalTrials.gov registry record
Prospective Registry of Histotripsy for Soft Tissue Tumors
A clinical trial of Soft Tissue Lesion and Soft Tissue Neoplasm, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07470008: Recruiting study of Soft Tissue Lesion and Soft Tissue Neoplasm, sponsored by University of California, San Francisco.
NCT07470008 is a study of Soft Tissue Lesion and Soft Tissue Neoplasm that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07470008, a study of Soft Tissue Lesion and Soft Tissue Neoplasm, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.
Primary Outcome
Imaging studies will be conducted to assess for a response across all participants (complete response (CR), Partial response (PR), Stable Disease (SD) and Progressive disease (PD) etc.) using the standardized criteria for tumor response assessment. The standard criteria for European Association for the Study of the Liver (EASL), Response Evaluation Criteria in Solid Tumors (RECIST), and modified RECIST (mRECIST) will be used to determine response depending on the participant's soft tissue tumor
Conditions Studied
Interventions
- OTHER Medical Record Review
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-01-29 |
| Est. Completion | 2031-08-08 |
What NCT07470008 shows while recruiting
NCT07470008 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Soft Tissue Lesion appearing as the primary indexed condition, and to 1 intervention - of which Medical Record Review is the first listed.
NCT07470008 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07470008 about?
NCT07470008 is a clinical study titled "Prospective Registry of Histotripsy for Soft Tissue Tumors". Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gat...
What is the current status of trial NCT07470008?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-01-29. Estimated completion is 2031-08-08.
What conditions does trial NCT07470008 study?
This clinical trial studies the following conditions: Soft Tissue Lesion, Soft Tissue Neoplasm, Soft Tissue Cancer.
What interventions are being tested in trial NCT07470008?
The interventions under investigation include: Medical Record Review (OTHER).
Who is sponsoring clinical trial NCT07470008?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07470008 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Soft Tissue Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI